Published: Thu, October 12, 2017
Business | By Max Garcia

Analysts Review: Repros Therapeutics (RPRX)


(RPRX) were valued at $0.75 and moved 41.51% as of a recent closing trade. The latest exchange of 2.85 Million shares is below its average trading activity of 291.76 Million shares. Unusual volume shows something has likely happened in the stock-such as a news release or traders have become anxious or euphoric about the stock's potential. Relative volume is a great indicator to keep a close eye on, but like most indicators it works best in conjunction with other indicators and on different time frames. It can't tell you the direction of the stock but indicates how likely the price is to change. (NASDAQ:RPRX) shares can stay above the price resistance around $0.83 a share, that could help propel Repros Therapeutics Inc. The company has its outstanding shares of 36.34M. (RPRX) has been moved; whether it performed well or not. The company reported the earnings of $-0.08/Share in the last quarter where the estimated EPS by analysts was $-0.22/share.

The company's stock is now moving with a -ve distance from the 200 day SMA of approximately -32.72%, and has a solid year to date (YTD) performance of -59.85% which means that the stock is constantly adding to its value from the previous fiscal year end price.

In recent trading day Repros Therapeutics Inc. The stock has a beta value of 0.38. Moving toward the technical facts, its current distance from 20-Day Simple Moving Average is 129.20% and standing 135.77% away from 50-Day Simple Moving Average while traded down -4.28% from 200-Day Simple Moving Average. Repros Therapeutics (RPRX)'s Williams Percent Range or 14 day Williams %R now sits at -38.20. Where the relative strength index (RSI) is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine excess buying & selling conditions of an asset, it is one of the most popular technical indicators, computed on the basis of the speed and direction of a stock's price movement. Analysts use common formulas and ratios to accomplish this. The company now has a Return on Equity of 8.20% and Return on Investment of 5.70%. A high ROE indicates successfully earning more assets and value for its shareholders off its reinvested earnings. For the past 5 years, the company's revenue has grown 81.8%, while the company's earnings per share has grown 0%. The stock volatility for the week was 41.79% while for the month was 17.55%. The average true range (ATR) is a measure of volatility introduced by Welles Wilder. Simply put, volatility is a reflection of the degree to which price moves. In general, if the indicator goes above -20, the stock may be considered overbought. A stock that maintains a relatively stable price has low volatility. The stock was trading at a distance of -65.60% from its 52-week highs and stands 188.46% away from its 52-week lows. When investing in a volatile security, the risk of success is increased just as much as the risk of failure. The trading saw a strength at $2.15, the 52-week high.

Analyst mean recommendation rating on a stock by the analyst community is at 2.00. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data.

Like this: